Literature DB >> 24999591

IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood.

Claire Q F Wang1, Mayte Suárez-Fariñas2, Kristine E Nograles1, Claudia A Mimoso1, David Shrom3, Ernst R Dow3, Michael P Heffernan3, Robert W Hoffman3, James G Krueger4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24999591     DOI： 10.1038/jid.2014.268

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  29 in total

1.  Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.

Authors:  T Tzellos; A Kyrgidis; C C Zouboulis
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03-08       Impact factor: 6.166

2.  CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells.

Authors:  T Holm; J K Damås; K Holven; I Nordøy; F R Brosstad; T Ueland; T Währe; J Kjekshus; S S Frøland; H G Eiken; N O Solum; L Gullestad; M Nenseter; P Aukrust
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

3.  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

Authors:  Lennart T H Jacobsson; Carl Turesson; Anders Gülfe; Meliha C Kapetanovic; Ingemar F Petersson; Tore Saxne; Pierre Geborek
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

4.  Cytokine profiles during infliximab monotherapy in psoriatic arthritis.

Authors:  A Mastroianni; E Minutilli; A Mussi; V Bordignon; E Trento; G D'Agosto; P Cordiali-Fei; E Berardesca
Journal:  Br J Dermatol       Date:  2005-09       Impact factor: 9.302

5.  The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.

Authors:  K Abuabara; H Lee; A B Kimball
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

6.  IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.

Authors:  James G Krueger; Scott Fretzin; Mayte Suárez-Fariñas; Patrick A Haslett; Krista M Phipps; Gregory S Cameron; Juliet McColm; Artemis Katcherian; Inna Cueto; Traci White; Subhashis Banerjee; Robert W Hoffman
Journal:  J Allergy Clin Immunol       Date:  2012-06-05       Impact factor: 10.793

7.  Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice.

Authors:  Rute Moura; Marc Tjwa; Petra Vandervoort; Soetkin Van Kerckhoven; Paul Holvoet; Marc F Hoylaerts
Journal:  Circ Res       Date:  2008-09-25       Impact factor: 17.367

Review 8.  Role of colony-stimulating factors in atherosclerosis.

Authors:  Karina Di Gregoli; Jason L Johnson
Journal:  Curr Opin Lipidol       Date:  2012-10       Impact factor: 4.776

9.  Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Authors:  K A Papp; C E M Griffiths; K Gordon; M Lebwohl; P O Szapary; Y Wasfi; D Chan; M-C Hsu; V Ho; P D Ghislain; B Strober; K Reich
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

10.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551
View more
  15 in total

Review 1.  Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR.

Authors:  April W Armstrong; Kim Papp; Leon Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

2.  Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris.

Authors:  A Chiricozzi; M Suárez-Fariñas; J Fuentes-Duculan; I Cueto; K Li; S Tian; C Brodmerkel; J G Krueger
Journal:  Br J Dermatol       Date:  2015-11-11       Impact factor: 9.302

3.  IκBζ is a key driver in the development of psoriasis.

Authors:  Claus Johansen; Maike Mose; Pernille Ommen; Trine Bertelsen; Hanne Vinter; Stephan Hailfinger; Sebastian Lorscheid; Klaus Schulze-Osthoff; Lars Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

4.  An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.

Authors:  Amy S Paller; Yael Renert-Yuval; Maria Suprun; Hitokazu Esaki; Margeaux Oliva; Thy Nhat Huynh; Benjamin Ungar; Norma Kunjravia; Rivka Friedland; Xiangyu Peng; Xiuzhong Zheng; Yeriel D Estrada; James G Krueger; Keith A Choate; Mayte Suárez-Fariñas; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

Review 5.  New therapies for psoriasis and psoriatic arthritis.

Authors:  Christopher T Ritchlin; James G Krueger
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

6.  Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites.

Authors:  William R Swindell; Mrinal K Sarkar; Philip E Stuart; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Clin Transl Med       Date:  2015-03-19

7.  The Act1 D10N missense variant impairs CD40 signaling in human B-cells.

Authors:  Ning Yu; Sylviane Lambert; Joshua Bornstein; Rajan P Nair; Charlotta Enerbäck; James T Elder
Journal:  Genes Immun       Date:  2018-01-05       Impact factor: 2.676

8.  TargetScore used to reveal potential targets of miRNA203 and miRNA-146a in psoriasis by integrating microRNA overexpression and microarray data.

Authors:  Hai-Xia Chen; Yan-Song Liu; Xiu-Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

9.  Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules.

Authors:  Dan Ilkovitch; Laura K Ferris
Journal:  Mol Med Rep       Date:  2016-08-26       Impact factor: 2.952

Review 10.  The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.

Authors:  Andrew Blauvelt; Andrea Chiricozzi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.